Home NDC 55154-5159 ULORIC
Product NDC 55154-5159
11-digit product format 551545159
Labeler code 55154
Product ID 55154-5159_3d9127b7-1357-46b2-8782-9d84130b92b7
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name febuxostat
Dosage form TABLET
Route ORAL
Labeler Cardinal Health
Application NDA021856
Marketing category NDA
Marketing start 2009-02-13
Marketing end 2023-08-31
Substance FEBUXOSTAT
Active strength 80 mg/1
Pharmacologic classes Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 55154-5159-8 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 55154-5159-8 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 55154-5159-8 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 55154-5159-8 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 55154-5159-8 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 55154-5159-8 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 55154-5159-8 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 55154-5159-8 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 55154-5159-8 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 55154-5159-8 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 55154-5159-8 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 55154-5159-8 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021856-001 ULORIC FEBUXOSTAT 40MG TABLET / ORAL AB RLD 2009-02-13 N021856-002 ULORIC FEBUXOSTAT 80MG TABLET / ORAL AB RLD, RS 2009-02-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021856-001 8372872 2031-09-08 U-1346 2013-02-26 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 N021856-002 8372872 2031-09-08 U-1346 N021856-002 9107912 2031-09-08 U-1346 2015-09-03
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021856-001 ULORIC 40MG TABLET / ORAL AB RLD 2009-02-13 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021856-002 ULORIC 80MG TABLET / ORAL AB RLD, RS 2009-02-13 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
Observed Orange Book patent history# Patent history page 1 of 7 · 254 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021856-002 8372872 2031-09-08 U-1346 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021856-002 9107912 2031-09-08 U-1346 2015-09-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021856-002 8372872 2031-09-08 U-1346 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021856-002 9107912 2031-09-08 U-1346 2015-09-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021856-002 8372872 2031-09-08 U-1346 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021856-002 9107912 2031-09-08 U-1346 2015-09-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021856-002 8372872 2031-09-08 U-1346 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021856-002 9107912 2031-09-08 U-1346 2015-09-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021856-002 8372872 2031-09-08 U-1346 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021856-002 9107912 2031-09-08 U-1346 2015-09-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021856-002 8372872 2031-09-08 U-1346 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021856-002 9107912 2031-09-08 U-1346 2015-09-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021856-001 7361676 2024-03-08 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021856-002 7361676 2024-03-08 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021856-002 8372872 2031-09-08 U-1346 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021856-002 9107912 2031-09-08 U-1346 2015-09-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021856-001 7361676 2024-03-08 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021856-002 7361676 2024-03-08 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021856-002 8372872 2031-09-08 U-1346 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021856-002 9107912 2031-09-08 U-1346 2015-09-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021856-001 7361676 2024-03-08 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021856-001 8372872 2031-09-08 U-1346 2013-02-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021856-001 9107912 2031-09-08 U-1346 2015-09-03 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021856-002 7361676 2024-03-08 Drug product 5bbf6a4d5a75…
Observed Orange Book exclusivity history# DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ULORIC FEBUXOSTAT Takeda Pharmaceuticals America, Inc. 54de10ef-fe5f-4930-b91d-6bbb04c664bd 2025-12-24 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 021856 application number: NDA021856
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 55154-5159-8 55154515908 900 TABLET in 1 BOTTLE, PLASTIC (55154-5159-8) 900 tablet 2009-02-13 2023-08-31 No No Current